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The concentrations of polychlorinated
biphenyls (PCBs) have, in general, decreased
in both humans and wildlife (Bignert et al.
1998; Norén and Meironyte 2000; Norstrom
et al. 1988; Schade and Heinzow 1998).
However, their high chemical stability, persis-
tence, pronounced lipophilicity, and tendency
to bioaccumulate, as well as their extensive
technical production and use from 1929 to
the 1970s, still make PCBs one of the world’s
most widespread and problematic classes of
environmental contaminants (Erickson 2001;
Safe 1993).
PCB concentrations found in humans
vary greatly, but commonly they are in the
hundreds of nanograms per gram of lipid if
presented as the sum of PCBs (ΣPCBs) (James
et al. 2002; Sjödin et al. 2000). Higher PCB
concentrations have been observed for popula-
tions exposed to PCBs via certain food
sources, such as sea mammals and/or fish
(Asplund et al. 1994; Ayotte et al. 1997;
Fängström et al. 2002; He et al. 2001; Hsu
et al. 1985; Sandau et al. 2000; Sjödin et al.
2000), or other routes of exposure. Accidental
intake of PCBs may cause elevated concentra-
tions of this class of compounds, as was the
case in Belgium in 1999 when animal feeds
were accidentally contaminated by PCBs
(Bernard and Fierens 2002; Bernard et al.
1999). Toxicologic effects of PCBs observed
in animal studies include carcinogenicity,
reproductive impairment, neurodevelop-
mental anomalies, and immunologic defi-
ciency (Brouwer et al. 1998; Faroon et al.
2001a, 2001b; Seegal 1996). However, not all
of these outcomes have been shown in
humans. Moreover, it is not clear whether
effects observed in humans were caused by the
PCBs themselves or by related compounds.
Jacobson and Jacobson (1996, 2004) reported
adverse effects of prenatal PCB exposure
(> 1.25 μg/g lipid) on neurodevelopment and
intellectual behavior in infants and young
children from Michigan, and similar results
have been reported in cohorts living elsewhere
(Patandin et al. 1999; Stewart et al. 2004;
Winneke et al. 2002).
Over the last decade attention has been
drawn to OH-PCBs that are metabolites of
PCBs and their potential role in early
development (Brouwer et al. 1998; Letcher
et al. 2000; Meerts et al. 2004a, 2004b).
OH-PCB metabolites are predominantly
formed from PCB congeners via cytochrome
P450 (CYP450)-mediated oxidation (Letcher
et al. 2000). The hydroxyl group on a biphenyl
is in general inserted via arene oxide formation,
possibly followed by 1,2 shift (NIH shift)
(Guroff et al. 1967; Jerina and Daly 1974).
Alternatively OH-PCB metabolites may be
formed via direct insertion of the hydroxyl
group (Koga et al. 1995). The metabolism of
PCB congeners results in the formation of a
very large number of OH-PCB congeners
(Bergman et al. 1994; Letcher et al. 2000;
Sjödin et al. 1998). OH-PCB metabolites with
a para- or a meta-substituted hydroxyl group
with adjacent chlorine atoms in the ortho and
meta positions have a high affinity for
transthyretin (TTR), a thyroxine (T4) trans-
port protein (Lans et al. 1993). A set of struc-
turally known OH-PCB metabolites are strong
T4 competitors for TTR (Brouwer et al. 1990,
1998; Lans et al. 1993, 1994; Purkey et al.
2004). Due to the ability of TTR to pass the
placental and blood–brain barriers, OH-PCBs
can be preferentially transferred to the fetal
compartment. In rodents, where TTR is the
only T4 binding protein (Brouwer et al. 1998;
Darnerud et al. 1996; Meerts et al. 2002;
Morse et al. 1996; Sinjari and Darnerud
1998), OH-PCBs induce hypothyroidism in
brain tissue. TTR is one of three T4 carriers in
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OBJECTIVE: Our aim in the present study was to characterize and quantify the levels of polychlorinated
biphenyls (PCBs) and speciﬁc polychlorobiphenylol (OH-PCB) metabolites in maternal sera from
women delivering in eastern Slovakia.
DESIGN: During 2002–2004, blood samples were collected from women delivering in two Slovak
locations: Michalovce district, where PCBs were formerly manufactured, and Svidnik and Stropkov
districts, about 70 km north.
PARTICIPANTS: A total of 762 and 341 pregnant women were sampled from Michalovce and
Svidnik/Stropkov, respectively, and OH-PCBs were measured in 131 and 31.
EVALUATION/MEASUREMENTS: We analyzed PCBs using gas chromatography (GC)/electron capture
detection. OH-PCBs and pentachlorophenol (PCP) were determined as methyl derivatives using
GC-electron capture negative ionization/mass spectrometry. We characterized distributions in the
full cohort using inverse sampling weights.
RESULTS: The concentrations of both PCBs and OH-PCB metabolites of Michalovce mothers were
about two times higher than those of the Svidnik/Stropkov mothers (p < 0.001). The median
weighted maternal serum levels of the sum of PCBs (ΣPCBs) were 5.73 ng/g wet weight (Michalovce)
and 2.82 ng/g wet weight (Svidnik/Stropkov). The median sum of OH-PCBs (ΣOH-PCBs) was
0.55 ng/g wet weight in Michalovce mothers and 0.32 ng/g wet weight in Svidnik/Stropkov mothers.
4-OH-2,2´,3,4´,5,5´,6-Heptachlorobiphenyl (4-OH-CB187) was a primary metabolite, followed by
4-OH-2,2´,3,4´,5,5´-hexachlorobiphenyl (4-OH-CB146). Only four PCB congeners—CBs 153,
138, 180, and 170—had higher concentrations than 4-OH-CB187 and 4-OH-CB146 (p < 0.001).
The median ratio of the ΣOH-PCBs to the ΣPCBs was 0.10.
CONCLUSIONS: Mothers residing in eastern Slovakia are still highly exposed to PCBs, and their
body burdens of these pollutants and OH-PCB metabolites may pose a risk for adverse effects on
health for themselves and their children.
KEY WORDS: hydroxylated PCB metabolites, maternal blood serum, OH-PCBs, PCBs, PCP, penta-
chlorophenol, polychlorinated biphenyls, Slovakia. Environ Health Perspect 114:20–27 (2007).
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cause fetal hypothyroidism through disruption
of T4 homeostasis by deiodination (Brouwer
et al. 1998) and sulfation (Schuur et al. 1998a,
1998b). OH-PCBs have recently been shown
to be more efﬁciently transferred to the fetal
compartment than their parent compounds
(Meironyté Guvenius et al. 2003; Soechitram
et al. 2004).
We conducted this investigation as part of
a birth cohort study of PCBs and early child-
hood development. Details on the study design
and background have been presented elsewhere
(Hertz-Picciotto et al. 2003). The Chemko,
Inc., chemical plant located in the Michalovce
district of the Slovak Republic produced PCBs
under the name of “Delor” from 1959 to
1984. A large quantity of PCB waste generated
during the PCB manufacture was released into
the surrounding area by improper disposal,
resulting in high environmental PCB levels in
various matrices in the Michalovce district, for
example, in air, soil, sediment, water, ﬁsh, and
wildlife (Kocan et al. 2001). Concentrations of
PCBs in human blood were far higher than in
other areas of Slovakia (Hovander et al. 2006;
Kocan et al. 1994; Pavuk et al. 2004).
The objective of the present study was to
assess OH-PCB and PCB congener concen-
trations and patterns in mothers delivering in
two districts of eastern Slovakia. Ultimately,
we hope to improve understanding of the
relationship between OH-PCBs and immune
and neurobehavioral development. We
characterized and quantified the levels of 
specific OH-PCB metabolites in maternal
sera collected at delivery. Also, we analyzed
pentachlorophenol (PCP) because it is known
to be a major blood contaminant (Hovander
et al. 2002; Meironyté Guvenius et al. 2003;
Sandau et al. 2000).
Materials and Methods
Cohorts and samples. We collected blood sam-
ples from mothers delivering in the Michalovce
district (population, 110,000), home to a
chemical manufacturing facility (Chemko
Strazske) that produced PCBs from 1959 to
1984, and from the Svidnik and Stropkov dis-
tricts (population, 55,000), which have lower
PCB exposures but similar population charac-
teristics (Demographic Research Center,
Bratislava). During the period 2002–2004,
mothers delivering in these areas were enrolled
in a birth cohort study. Hospital staff trained
in the study protocols explained the study and
obtained consent before collection of data, and
collected blood samples from mothers at time
of delivery. The study participants gave written
informed consent. A total of 762 and 341
women were sampled from Michalovce and
Svidnik/Stropkov, respectively. This study
complied with all applicable U.S. and inter-
national requirements with regard to research
on human subjects and was approved by the
respective institutional review boards at the
University of California-Davis and the Slovak
Medical University (formerly The Institute for
Preventive and Clinical Medicine).
Whole maternal blood (20 mL) was col-
lected from subjects just before the delivery into
three 9-mL vacutainer tubes (S-Monovette,
Sarstedt, Germany) without anticoagulants.
The blood samples were allowed to clot ≤ 2h r
at 5–10°C. After clotting, blood was cen-
trifuged at 3,000 rpm for 15 min. Isolated
serum was stored frozen at –18°C in pre-
cleaned glass tubes with polytetrafluoro-
ethylene liner screw caps. We transported all
the samples by car to the Slovak Medical
University (SMU) laboratory in Bratislava in
thermo boxes to prevent thawing. We stored
the samples in freezers at –18°C until analysis.
Aliquots of 5 mL were shipped to the
University of California-Davis and stored at
–80°C until analysis of OH-PCB metabolites.
We asked the mothers who participated in this
study to complete questionnaires (e.g., age,
diet, number of children, residence, lifestyle,
ethnicity, education). Based on the maternal
serum concentrations of PCBs measured for
this study, we selected a stratified random
sample of the specimens for the analysis of
OH-PCB metabolites. We assigned probabili-
ties of selection such that those at the low end
of the PCB distribution had the lowest proba-
bility of selection, and those at the upper end
had the highest probability.
Chemicals and instruments. The organic
solvents and adsorbents used in the analysis
and the authentic reference standards used for
the identification and quantification of the
analytes are described in Table 1. We followed
the numbering of OH-PCBs as proposed else-
where (Hovander et al. 2002). OH-PCBs and
PCP in the ﬁnal extracts were determined as
methyl derivatives by using an Agilent 6890
gas chromatograph (Agilent Technologies,
Palo Alto, CA, USA) equipped with an
Agilent 5973N mass spectrometer (Agilent
Technologies). Individual methyl derivatives
prepared after methylation of authentic refer-
ence standards were injected in the gas chro-
matograph (GC)/mass spectrometer operated
in electron capture negative ionization (ECNI)
full scan mode. The observed mass spectra and
retention time were used for identiﬁcation of
the analytes. Helium was used as carrier gas.
The mass spectrometer was operated in ECNI
mode with electron energy of 130 eV.
Methane (99.99% pure) was used as a reagent
gas, and source pressure was 2.0 × 10–4 torr at
the inlet. The GC was equipped with DB-
5MS capillary column (30 m × 0.25 mm i.d.,
0.25 μm ﬁlm thickness; J&W Scientiﬁc Inc.,
Folsom, CA, USA). Injection (2 μL) was made
in pulsed splitless mode with an injector tem-
perature of 250°C. The initial GC tempera-
ture was set to 80°C and held for 2 min,
followed by a 50°C/min increase to 200°C,
1°C/min to 230°C, and 30°C/min to 300°C,
and held for 4 min. Postrun was set to 320°C
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Table 1. Chemicals and authentic reference standards.
Chemical Provider
Chemical (grade)
Hexane (trace analysis)  Burdick & Jacksona
Dichloromethane (trace analysis)  Burdick & Jackson
Methyl-tert butyl ether (HPLC)  Fisher Scientiﬁcb
Methanol (purge and trap)  Fisher Scientiﬁc
Water (HPLC)  Burdick & Jackson
2-Propanol (99.9%, pesticide)  Sigma-Aldrichc
Hydrochloric acid  Fisher Scientiﬁc
H2SO4 (98%) Fisher  Scientiﬁc
Potassuim hydroxide  Fisher Scientiﬁc
Potassuim chloride  Fisher Scientiﬁc
Sodium hydroxide  Fisher Scientiﬁc
Ethyl alcohol (99.9%, 200 proof) Gold Shieldd
N-Nitroso-N-methylurea Sigma-Aldrich
Silica (200–400 mesh)  Sigma-Aldrich
Standard (purity), chemical namee
4-OH-CB107 (> 98%), 4-OH-2,3,3´,4´,5-pentachlorobiphenyl  Wellington Laboratoryf
3-OH-CB153, 3-OH-2,2´,4,4´,5,5-hexachlorobiphenyl  Stockholm Universityg
4-OH-CB146 (> 98%), 4-OH-2,2´,3,4´,5,5´-hexachlorobiphenyl  Wellington Laboratory
3´-OH-CB138 (> 98%), 3´-OH-2,2´,3,4,4´,5´-hexachlorobiphenyl  Wellington Laboratory
4´-OH-CB130 (> 98%), 4´-OH-2,2´,3,3´,4,5´-hexachlorobiphenyl  Wellington Laboratory
4-OH-CB187 (> 98%), 4-OH-2,2´,3,4´,5,5´,6-heptachlorobiphenyl  Wellington Laboratory
4´-OH-CB159 (> 98%; IS), 4´-OH-2,3,3´,4,5,5´-hexachlorobiphenyl AccuStandardh
3´-OH-CB180 (> 98%), 3´-OH-2,2´,3,4,4´,5,5´-heptachlorobiphenyl  Wellington Laboratory
4´-OH-CB172 (> 98%), 4´-OH-2,2´,3,3´,4,5,5´-heptachlorobiphenyl  Wellington Laboratory
4-OH-CB193, 4-OH-2,3,3´,4´,5,5´,6-heptachlorobiphenyl  Stockholm University
PCP (> 95%) Ultra Scientiﬁci
IS, internal standard.
aMuskegon, MI, USA. bPittsburgh, PA, USA. cSt. Louis, MO, USA. dHayward, CA, USA. eThe numbering of OH-PCBs follows
that used by Hovander et al. (2002). fGuelph, Ontario, Canada. gStockholm, Sweden. hNew Haven, CT, USA. iNorth
Kingstown, RI, USA.for 1 min. The temperatures for both ion
source and quadruple ﬁeld were set to 150°C.
Selective ion monitoring (SIM) was used to
monitor two ions for each compound: one for
quantiﬁcation and the other for conﬁrmation.
For most OH-CB congeners and PCP, the
molecular ions were monitored as the base
peak. However, the most abundant fragment
ions [(M+2-HCl)–] were monitored for meta-
substituted congeners (e.g., 3´-MeO-CB138
and 3-MeO-CB153) because their molecular
ions were weak in intensity.
Analysis and cleanup. We analyzed mater-
nal blood sera specimens for 17 PCB con-
geners (CBs 28, 52, 101, 123/149, 118, 114,
153, 105, 138, 167, 156/171, 157, 180, 170,
and 189) at the Slovak Medical University.
The analytical procedures are described in
detail elsewhere (Kocan et al. 1994; Pavuk
et al. 2004). The total lipid content was meas-
ured enzymatically (Akins et al. 1989). We
analyzed the selected samples (n = 166) for
nine OH-PCB congeners and PCP at the
University of California-Davis. Maternal sera
specimens were weighed in precleaned glass
tubes (25 mL) with polytetrafluoroethylene
liner screw caps. The extraction method was
adopted to separate phenolic compounds (e.g.,
OH-PCBs, PCP) from maternal serum
(Hovander et al. 2000). The procedures of
methyl derivatization and purification were
optimized for this study. Briefly, maternal
serum (5 g) was denaturized with 1 mL of
6 M hydrochloric acid and 6 mL 2-propanol
and extracted using 6 mL hexane:methyl-tert-
butyl ether (MTBE) (1:1; reextraction with
3 mL). After potassium chloride wash, the
extracts were phase-separated by adding 2 mL
potassium hydroxide solution. After the neu-
tral fraction was extracted, the alkaline aque-
ous solutions (potassium hydroxide) were
acidified with 2 M hydrochloric acid and
extracted for phenolic compounds with 4 mL
hexane:MTBE (9:1; reextraction with 3 mL).
The phenolic extracts were further dried by
passing them through anhydrous sodium sul-
fate–packed Pasteur pipette columns. The
volumes of phenolic extracts and ﬁve calibra-
tion standards were reduced to < 50 μL. Five
drops of methanol were added to all sample
extracts to complete the derivatization and to
give the extracts similar properties to calibra-
tion standards in methanol. Phenolic com-
pounds in the sample extracts and calibration
standards were methylated by adding 1 mL
diazomethane. We synthesized diazomethane
in hexane by using N-nitroso-N-methylurea
(Sigma-Aldrich, St. Louis, MO, USA) as
described by Sandau (2000). The glass tubes
containing the mixtures were tightly capped,
placed in a dark box, and left for 24 hr in a
ventilation hood.
In this study, we compared two different
cleanup methods to improve the removal of
any coextracted biogenic residues. For the ini-
tial 60 samples, the derivatives were puriﬁed
on a 22% sulfuric acid (H2SO4)/silica column
(1.5 g) with 40 mL dichloromethane
(DCM):hexane (1:1) as the mobile phase,
using custom-made glass columns (23 cm ×
0.6 cm i.d.) with a 50-mL reservoir. For the
rest of the samples (n = 106), the extracts
were first treated with concentrated H2SO4
(98%) and then further cleaned up with 1:2
H2SO4:silica gel (weight/weight; 0.5 g) col-
umn and 10 mL DCM:hexane (1:1) as mobile
phase. For both methods, the silica gel was
activated at 550°C. The volumes of eluates and
calibration standards were reduced to 200 μL
as a final volume, spiked with CB-209
(3.15 ng) as an injection standard, and trans-
ferred to brown GC vials with silanized inserts.
Quantification and quality assurance/
quality control. All glassware was washed, dried
by acetone and hexane, and baked at 550°C
for 8 hr. For the analysis of OH-PCB metabo-
lites, each batch included 1 reagent blank (1%
potassium chloride solution), 1–2 control sam-
ples, and 10 serum specimens. Five levels of
calibration standards for the quantification
were prepared in methanol and stored in
brown ampules in a refrigerator. The cali-
bration range was 0.1–50 pg/μL. For control
samples, we obtained human adult serum sam-
ples (n = 3) from the Center for Blood
Research (Sacramento, CA, USA); the samples
were pooled and measured for PCP and OH-
PCBs. Subsequently, PCP and OH-PCB stan-
dards were fortiﬁed to the pooled serum. We
used the sum of measured and fortiﬁed com-
pounds as a ﬁnal concentration to determine
the recoveries of analytes. After several recovery
tests on the pooled serum for consistency, it
was aliquoted in glass tubes, wrapped in alu-
minum foil, and stored at –20°C until analysis.
For the quantiﬁcation, we used ﬁve OH-PCB
external calibration standards derivatized
simultaneously with the serum sample extracts
for accurate quantification. 4´-OH-CB159
(4´-OH-2,3,3´,4,5,5´-hexachlorobiphenyl;
2.00 ng) was added to all samples before
extraction as a recovery internal standard.
Statistical analysis. Because we selected the
subsample for OH-PCB assays based on strata
defined by PCB concentration, the distribu-
tion of PCBs and OH-PCB concentrations
were represented by their means and medians
obtained using weights proportional to the
inverse of the sampling fractions. However, we
report the measured concentrations of PCP as
randomly selected because PCP was not associ-
ated with PCBs. We report the concentration
of phenolic compounds, OH-PCBs, and PCP
on a wet weight (ww) basis because they are
not accumulated in lipids but have high afﬁn-
ity to blood proteins (Bergman et al. 1994;
Letcher et al. 2000). We conducted parametric
tests for log-normally distributed PCB and
OH-PCB data to determine the differences
and relationships. After log transformation, we
calculated R 2 values from a weighted Pearson
correlation analysis to determine the relation-
ships between individual PCBs and their pre-
sumed metabolites in maternal serum. After log
transformation, we conducted Student t-tests to
determine differences in the concentrations
between Michalovce and Svidnik/Stropkov
mothers, and between PCBs and their metabo-
lites. We used the nonparametric Mann-
Whitney test for PCP data, which were not
normally distributed.
Results 
We report results for nine OH-PCB congeners,
their sum, and PCP for the 166 maternal serum
specimens. The recoveries from control samples
in a total of 18 batches ranged from 75 ± 9%
[4´-OH-CB130 (4´-OH-2,2´,3,3´,4,5´-hexa-
chlorobiphenyl)] to 101 ± 11% [4-OH-CB146
(4-OH-2,2´,3,4´,5,5´-hexachlorobiphenyl)].
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Figure 1. Percent recovery of OH-PCBs from spiked control serum samples applying two different cleanup
procedures. IS, internal standard.
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H2SO4 treatment + H2SO4/silica gel (n = 20)The differences between the two cleanup meth-
ods with regard to the recovery of analytes from
control samples are shown in Figure 1. Most
recoveries of the internal standard (4´-OH-
CB159) fell between 60 and 110%, with an
average of 84 ± 16%. Twenty samples had
lower recoveries (40–60%). Of 166 samples, 4
were omitted from the statistical summary:
3 because the recoveries of internal standards
were < 30%, and 1 because the PCB concentra-
tions in this Svidnik/Stropkov mother were far
outside the range for other mothers in the dis-
tricts, raising concern about contamination. We
corrected all other serum concentrations of
OH-PCBs using the recoveries of internal stan-
dards and subtracting the quantity measured in
each reagent blank analyzed in the same batch.
Table 2 presents demographic and lifestyle
characteristics, including age, parity, body
mass index, education, marital status, and
smoking during pregnancy for the 131 sub-
jects from Michalovce district and the 31 from
Svidnik/Stropkov districts. Compared with
the total population in this study, the
Michalovce subsample has more first-time
mothers (data not shown). The concentrations
of lipids, various individual and summed
PCBs and OH-PCBs, and PCP are presented
in Tables 3 and 4. Lipid content in maternal
serum was similar in samples from Michalovce
compared with those from Svidnik/Stropkov,
with medians of 1.02% and 1.01%, respec-
tively. The mean concentrations of both PCBs
and OH-PCB metabolites in sera from
Michalovce mothers were about twice as high
as in sera from Svidnik/Stropkov mothers
(p < 0.001). The ratios tended to be even
higher at the 95th percentiles. Median mater-
nal serum levels of the ΣPCBs were 5.73 ng/g
ww in Michalovce and 2.82 ng/g ww in
Svidnik/Stropkov (Table 3). The medians for
the sum of nine measured OH-PCB metabo-
lites were 0.55 ng/g ww in Michalovce moth-
ers and 0.32 ng/g ww in Svidnik/Stropkov
mothers (Table 4). 4-OH-CB187 (4-OH-
2,2´,3,4´,5,5´,6-heptachlorobiphenyl) was the
predominant congener in almost all samples,
followed by 4-OH-CB146. 4-OH-CB187
comprised 36 ± 6% of the ΣOH-PCBs we
measured, and combined with 4-OH-CB146,
accounted for 57 ± 8%. These two OH-PCBs,
combined with four other metabolites
[3-OH-CB153 (3-OH-2,2´,4,4´,5,5-hexa-
chlorobiphenyl), 3´-OH-CB138 (3´-OH-
2,2´,3,4,4´,5´-hexachlorobiphenyl),
4´-OH-CB172 (4´-OH-2,2´,3,3´,4,5,5´-
heptachlorobiphenyl), and 4-OH-CB107
(4-OH-2,3,3´,4´,5-pentachlorobiphenyl)],
constituted 93 ± 3% of the ΣOH-PCBs,
whereas 4´-OH-CB130, 3´-OH-CB180
(3´-OH-2,2´,3,4,4´,5,5´-heptachloro-
biphenyl), and 4-OH-CB193 (4-OH-
2,3,3´,4´,5,5´,6-heptachlorobiphenyl) were
detected only at trace levels in most samples.
The median PCP concentrations were
0.66 ng/g ww for the women from Michalovce
and 0.54 ng/g ww for the Svidnik/Stropkov
subjects.
The sum of six major OH-PCB metabo-
lites (see Table 4 footnote) from ﬁve different
geographic locations are summarized as
median or equivalent value (geometric mean)
and range (Figure 2): 0.52 and 0.30 ng/g ww
for mothers residing in Michalovce and
Svidnik/Stropkov, respectively (this study);
0.32 for mothers from the northern
Netherlands (Soechitram et al. 2004); 1.11 for
female Inuit in northern Canada (Sandau
et al. 2000); 0.12 for Swedish mothers
(Meironyté Guvenius et al. 2003); and 0.75
and 5.00 for low- and high-exposed Faroe
Island mothers, respectively (Fängström et al.
2002). Concentrations of OH-PCB metabo-
lites from Michalovce mothers were compara-
ble to those from Faroe Island mothers with
low fish consumption. In Figure 2, data on
3´-OH-CB138 was not included for northern
Canadian female Inuit because it was detected
only at trace levels (~ 3%). No data from Faroe
Island mothers is available for 4´-OH-CB172
PCBs and OH-PCB metabolites in Slovak mothers
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Table 3. Distributions of PCB congeners suggested to be precursors for OH-PCB metabolites, measured in
serum from Slovak mothers sampled at time of delivery. 
5th 25th  75th  95th 
percentile percentile Median percentile percentile Mean ± SD
Michalovce (n = 131)
Lipid (mg/mL) 7.80 9.44 10.2 11.3 13.8 10.5 ± 1.86
PCBs (ng/mL ww)
CB-118 0.02 0.06 0.13 0.20 0.56 0.19 ± 0.24
CB-153 0.57 1.21 1.66 2.65 5.72 2.29 ± 1.98
CB-105 < 0.007 0.01 0.02 0.04 0.10 0.04 ± 0.06
CB-138 0.38 0.78 1.05 1.74 3.81 1.49 ± 1.38
CB-180 0.46 1.12 1.63 2.46 5.32 2.16 ± 1.88
CB-170 0.22 0.48 0.68 1.06 2.26 0.93 ± 0.81
ΣPCBs 1.81 4.12 5.73 8.96 19.05 7.71 ± 6.60
Svidnik/Stropkov (n = 31)
Lipid (mg/mL) 7.39 8.52 10.1 10.8 13.5 9.82 ± 2.27
PCBs (ng/mL ww)
CB-118 0.02 0.05 0.07 0.13 0.22 0.09 ± 0.08
CB-153 0.44 0.65 0.92 1.24 1.94 1.05 ± 0.62
CB-105 < 0.007 0.01 0.01 0.02 0.04 0.02 ± 0.03
CB-138 0.27 0.39 0.55 0.86 1.32 0.67 ± 0.43
CB-180 0.32 0.57 0.93 1.17 1.71 0.92 ± 0.54
CB-170 0.16 0.25 0.40 0.47 0.77 0.40 ± 0.25
ΣPCBs 1.54 2.29 2.82 4.32 6.34 3.45 ± 1.97
These distributions represent the full cohort of 1,103 mothers and were obtained using weights inversely proportional to the
sampling probabilities. ΣPCBs includes CBs 28, 52, 101, 123/149, 118, 114, 153, 105, 138, 167, 156/171, 157, 180, 170, and 189.
Table 2. Characteristics of the participating women with OH-PCB measurements from the districts of
Michalovce (n = 131) and Svidnik/Stropkov (n = 31). 
Michalovce (%)  Svidnik/Stropkov (%)
Age (years)
< 21  17 (13.0)  7 (22.6) 
21–29  88 (67.2)  17 (54.8) 
≥ 30   24 (18.3)  7 (22.6) 
Missing 2  (1.53)  0 
Previous children (n) 
0 57 (43.5)  12 (38.7) 
1 35 (26.7)  8 (25.8) 
≥ 2 37 (28.2)  11 (35.5) 
Missing 2 (1.53)  0 
Body mass index (kg/m2)
< 23  82 (62.6)  17 (54.8) 
23–28  24 (18.3)  9 (29.0) 
> 28  11 (8.40)  2 (6.45) 
Missing 14 (10.7)  3 (9.68) 
Smoking 
No  82 (62.6)  19 (61.3) 
Yes  47 (35.9)  12 (38.7) 
Missing 2 (1.53)  0 
Education 
University  6 (4.58)  3 (9.68) 
High school graduate 60 (45.8)  16 (51.6) 
Lower education  63 (48.1)  12 (38.7) 
Missing 2 (1.53)  0 
Marital status 
Married  116 (88.6)  29 (93.6) 
Single, widowed, or divorced  9 (5.34)  2 (6.45) 
Missing 6 (4.58)  0because Fängström et al. (2002) did not
measure it. Although data from Swedish
mothers provided the sum of 12 OH-PCB
metabolites (Meironyté Guvenius et al.
2003), the concentrations were lowest among
the published studies. Faroe Island mothers in
1994–1995 (Fängström et al. 2002), espe-
cially frequent ﬁsh eaters, showed the highest
median concentration of OH-PCB metabo-
lites—4.5 times higher than northern
Canadian female Inuits in 1992 and 9.0 times
higher than Michalovce mothers during
2002–2004. However, Canadian female Inuit
showed the widest concentration range.
The sum of OH-PCB metabolites corre-
lated with the ΣPCBs (R 2 = 0.47, p < 0.001)
(Figure 3). The ratio of the ΣOH-PCBs to
the ΣPCBs ranged from 0.03 to 0.47, with a
median of 0.10. We also examined OH-PCB
metabolites in relation to potential or known
PCB precursors described by others (Letcher
et al. 2000; Sjödin et al. 1998). For instance,
4-OH-CB107 was transformed from CB-105
and CB-118; both CB-138 and CB-153 were
precursors for 4-OH-CB146; CB-170 and
180 were suggested as possible substrates for
4´-OH-CB172; and 3-OH-CB153 and
3´-OH-CB138 could be derived directly from
CB-153 and CB-138, respectively. We used a
correlation analysis to evaluate these biotrans-
formation pathways of PCB congeners. These
are shown in Figure 3; R 2 values ranged from
0.22 to 0.53.
The median concentration of the ΣPCBs
was an order of magnitude higher than that of
OH-PCBs (p < 0.001). However, the most
dominant OH-PCB metabolite, 4-OH-
CB187, showed significantly higher concen-
tration than CBs 28, 52, 101, 123/149, 114,
105, 167, 157, and 189 (p < 0.001 from all
individual tests). It was slightly higher than
CBs 118 and 156/171 but the difference was
still signiﬁcant (p < 0.001 from all individual
tests). Only CBs 153, 138, 180, and 170 were
significantly higher than 4-OH-CB187
(p < 0.001 from all individual tests).
The distributions of six individual
OH-PCB congeners in studies from various
locations are shown in Figure 4. The relative
abundances of these congeners are similar, with
the exception of 4-OH-CB107, which con-
tributes a larger proportion among the Inuits. 
Discussion
We found that 4-OH-CB107, 4-OH-CB187,
4-OH-CB146, 3-OH-CB153, 3´-OH-CB138,
and 4´-OH-CB172 were the major hydroxy-
lated PCB metabolites in most maternal serum
specimens collected from the two regions
(Michalovce and Svidnik/Stropkov districts).
Many other OH-PCB congeners have also
been identified in human blood (Hovander
et al. 2002; Sandau et al. 2000). With only
slight variation, the rank order of abundance of
individual OH-PCB metabolites we observed
in the present study was 4-OH-CB187
> 4-OH-CB146 > 3-OH-CB153 > 3´-OH-
CB138 > 4´-OH-CB172 > 4-OH-CB107. If
we can assume similar patterns of metabolic
pathways, the identical pattern of OH-PCB
congeners observed in the two regions might
indicate atmospheric transport, similar
upstream sources due to use of PCB-contain-
ing products in the past, or consumption of
food contaminated over a wider area than
Michalovce. The distribution of individual
Park et al.
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Table 4. Distributions of OH-PCB metabolites measured in serum from Slovak mothers sampled at the time
of delivery. 
5th 25th  75th  95th 
percentile percentile Median percentile percentile Mean ± SD
Michalovce (n = 131)
Lipid (mg/mL) 7.80 9.44 10.2 11.3 13.8 10.5 ± 1.86
HPCs (ng/g ww)
4-OH-CB107 0.01 0.02 0.03 0.05 0.15 0.05 ± 0.07
3-OH-CB153 0.02 0.05 0.07 0.11 0.27 0.10 ± 0.09
4-OH-CB146 0.03 0.06 0.11 0.18 0.47 0.17 ± 0.23
3'-OH-CB138 0.02 0.04 0.07 0.10 0.22 0.08 ± 0.08
4'-OH-CB130 < 0.003 < 0.003 0.003 0.01 0.01 0.01 ± 0.03
4-OH-CB187 0.07 0.11 0.20 0.36 0.85 0.31 ± 0.36
3'-OH-CB180 0.01 0.01 0.02 0.03 0.08 0.03 ± 0.03
4'-OH-CB172 0.01 0.02 0.04 0.07 0.15 0.06 ± 0.07
4-OH-CB193 0.01 0.01 0.02 0.03 0.08 0.03 ± 0.04
PCPa 0.24 0.41 0.66 1.04 3.24 1.02 ± 1.35
Sum of major OH-PCBsb 0.18 0.34 0.52 0.88 2.11 0.77 ± 0.85
ΣOH-PCBs 0.20 0.36 0.55 0.95 2.28 0.83 ± 0.91
OH-PCBs:PCBs 0.05 0.07 0.09 0.12 0.18 0.10 ± 0.05
Svidnik/Stropkov (n = 31)
Lipid (mg/mL) 7.39 8.52 10.1 10.8 13.5 9.86 ± 2.25
HPCs (ng/g ww)
4-OH-CB107 0.004 0.01 0.02 0.03 0.05 0.02 ± 0.01
3-OH-CB153 0.01 0.02 0.04 0.05 0.12 0.05 ± 0.04
4-OH-CB146 0.02 0.04 0.05 0.07 0.16 0.06 ± 0.05
3'-OH-CB138 0.01 0.02 0.03 0.05 0.13 0.04 ± 0.04
4'-OH-CB130 < 0.003 < 0.003 < 0.003 0.004 0.01 0.00 ± 0.00
4-OH-CB187 0.04 0.07 0.11 0.13 0.32 0.12 ± 0.08
3'-OH-CB180 < 0.003 0.01 0.01 0.01 0.03 0.01 ± 0.01
4'-OH-CB172 0.01 0.01 0.02 0.03 0.06 0.03 ± 0.02
4-OH-CB193 0.004 0.01 0.01 0.01 0.03 0.01 ± 0.01
PCPa 0.24 0.37 0.54 0.72 1.98 0.74 ± 0.78
Sum of major OH-PCBsb 0.11 0.19 0.30 0.38 0.93 0.32 ± 0.22
ΣOH-PCBs 0.12 0.21 0.32 0.43 1.01 0.35 ± 0.24
OH-PCBs:PCBs 0.04 0.07 0.08 0.11 0.16 0.10 ± 0.05
These distributions represent the full cohort of 1,103 mothers and were obtained using weights inversely proportional to
the sampling probabilities.
aPCP was reported as measured. bMajor OH-PCBs were 4-OH-CB107, 3-OH-CB153, 4-OH-CB146, 3´-OH-CB138,
4-OH-CB187, and 4´-OH-CB172.
Figure 2. Medians and ranges of maternal blood concentrations of major OH-PCB metabolites from five
other areas for comparison to present data. Abbreviations: FPE, female plasma equivalent; HFC, high ﬁsh
consumption; LFC, low ﬁsh consumption; MP, maternal plasma; MS, maternal serum. The samples were
collected for the Netherlands in 1998–2000 (Soechitram et al. 2004), Canadian Inuit in 1992 (Sandau et al.
2000), Sweden in 2000–2001 (Meironyté Guvenius et al. 2003), Faroe Islands in 1994–1995 (Fängström et al.
2002), and Michalovce and Svidnik/Stropkov in 2002–2004 (present study). The distribution for the Slovak
region represents the 1,103 mothers through weighting based on the sample design.
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We found 4-OH-CB187 to be a primary
OH-PCB metabolite in the maternal blood,
consistent with results from other studies
(Bergman et al. 1994; Fängström et al. 2002;
Klasson-Wehler et al. 1998; Meironyté
Guvenius et al. 2003; Soechitram et al. 2004),
whereas Sandau et al. (2000) observed
4-OH-CB107 to be a primary congener.
Sjödin et al. (2000) also determined that
4-OH-CB107 was a primary congener in
Baltic Sea ﬁshermen. 4-OH-CB146 has con-
sistently been found to be the second most
abundant metabolite in all locations.
The correlation between PCBs and
OH-PCB metabolites (R2 = 0.47, p < 0.001)
indicated that the blood levels of OH-PCB
metabolites were dependent on PCB levels.
The ratio of the ΣOH-PCBs to the ΣPCBs
was similar to that observed in other studies
(Letcher et al. 2000; Meironyté Guvenius
et al. 2003; Sandau et al. 2000; Sjödin et al.
2000; Soechitram et al. 2004). In other stud-
ies, lower ratios were sometimes related to
higher levels of PCBs, which has been hypoth-
esized to be due to faster elimination of
OH-PCBs as a result of the enhanced induc-
tion of phase II enzymes and conjugation
reactions (Letcher et al. 2000). In the present
study we found no relationship between PCB
levels and magnitude of the ratios. Several
OH-PCBs can be formed from each of the
persistent PCB congeners (e.g., CBs 118,
138, 153, 187) via a 1,2 shift of a chlorine
atom in the hydroxylation stage or via a direct
oxygen (hydroxyl group) insertion. Therefore,
it is impossible to predict the relative contri-
bution of PCB congeners to each specific
OH-PCB metabolite. An important factor for
the differences we observed must be the nat-
ural biological variability. The correlation
analysis in the present study supports a 1,2
shift of a chlorine atom as a more important
mechanism than direct insertion of oxygen in
the formation of OH-PCBs. For example,
pairs of 1,2 shift transformation (e.g., 4-OH-
CB146/CB-138 in Figure 3C, 4-OH-
CB146/CB-153 in Figure 3D) showed
stronger correlation (R2 = 0.52−0.53) than
those dominated by direct oxygen insertion
(e.g., 3´-OH-CB138/CB-138 in Figure 3E,
3-OH-CB153/CB-153 in Figure 3F) (R2 =
0.22). The CB-118 to 4-OH-CB107 rela-
tionship (Figure 3B) was weaker (R2 = 0.24)
than other associations related to a 1,2 shift
transformation. This may be due to its forma-
tion not only from CB-118 but also from
PCBs and OH-PCB metabolites in Slovak mothers
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Figure 3. Best ﬁtting linear regressions indicating statistical relationships between ΣPCBs and ΣOH-PCBs
(A; R2 = 0.47) and between specific PCB precursors and OH-PCB metabolites in maternal sera from
Slovakia: (B) CB-118 and 4-OH-CB107 (R2 = 0.24); (C) CB-138 and 4-OH-CB146 (R2 = 0.53); (D) CB-153 and
4-OH-CB146 (R2 = 0.52); (E) CB-138 and 3´-OH-CB138 (R2 = 0.22); (F) CB-153 and 3-OH-CB153 (R2 = 0.22);
(G) CB-180 and 4´-OH-CB172 (R2 = 0.39); and (H) CB-170 and 4´-OH-CB172 (R2 = 0.43).
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Figure 4. Distribution of major OH-PCB metabolites
found in human blood for six regions in Europe and
North America. (A) Netherlands (Soechitram et al.
2004), (B) Canadian Inuit (Sandau et al. 2000),
(C) Sweden (Meironyté Guvenius et al. 2003),
(D) Faroe Islands (Fängström et al. 2002),
(E) Michalovce (present study), and (F) Svidnik/
Stropkov (present study). NA, not available.
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)CB-105. The relationship we observed
between CB-118 and 4-OH-CB107 is slightly
weaker than that reported in other studies
(Sandau et al. 2000).
OH-PCB metabolites in Michalovce were
comparable to those in Faroe Island mothers
with low fish consumption (Figure 2). The
Faroe Island mothers with high ﬁsh consump-
tion showed much higher median concentra-
tion of OH-PCB metabolites than the subjects
of any other areas, including Michalovce
mothers and Canadian Inuit. The wide range
among the Inuits is probably because of a
wider age range (18–72 years) than in the
other studies, as it was not limited to pregnant
women. Generally, body burdens of PCBs are
positively correlated with age because of accu-
mulation and slow excretion, and accordingly,
OH-PCBs should correlate as well. Unlike in
the Slovak mothers, the high concentrations of
OH-PCBs found in Canadian Inuit and Faroe
Islanders (Figure 2) are related to ongoing ﬁsh
and sea mammal consumption. Total PCBs in
blubber of ringed seal and beluga whale (com-
mon in the Inuit diet) were 0.96–5.60 and
0.31–1.50 μg/g lipid, respectively (Sandau
et al. 2000); the concentration of total PCBs
in pilot whale blubber (Faroe Island diet) was
10–40 μg/g lipid (Fängström et al. 2002).
PCP was present in higher concentrations
than any of the OH-PCB metabolites. This is
in accordance with other studies (Meironyté
Guvenius et al. 2003; Sandau et al. 2000).
PCP has been extensively used as a fungicide
for wood preservation, which may be the rea-
son for its occurrence in our Slovakian subjects
(Halsall et al. 1998; Sandala et al. 2004; Wild
et al. 1992). PCP interferes with thyroid hor-
mones in blood (Beard et al. 1999; Ishihara
et al. 2003; van den Berg et al. 1991).
However, in contrast to OH-PCB metabolites,
the concentrations of PCP in the present study
were not significantly different between the
districts (Mann-Whitney test, p = 0.10); also,
PCP showed no correlation with OH-PCB
metabolites, supporting different sources of the
HPCs. The median and geometric mean con-
centrations of PCP (0.63 and 0.68 ng/g ww,
respectively) from eastern Slovak mothers were
substantially lower than in Swedish mothers
(median, 2.83; Meironyté Guvenius et al.
2003), and female Canadian Inuit (geometric
mean, 1.59; Sandau et al. 2000).
The higher concentrations of both PCBs
and OH-PCB metabolites in Michalovce
compared with Svidnik/Stropkov is consistent
with a cross-sectional study conducted just
before ours. During 2001–2002, Hovander
et al. (2006) analyzed six PCB congeners
(CB-101, 105, 118,-138, 153, and 187) and
three OH-PCB metabolites (4-OH-CB107,
4-OH-CB146, and 4-OH-CB187) in 122
plasma samples from Michalovce and 175
plasma samples from Svidnik/Stropkov from
the general human population. They found
median CB-153 concentrations of 0.57 μg/g
lipid (Michalovce) and 0.24 μg/g lipid
(Svidnik/Stropkov) compared with the values
of 0.16 μg/g lipid (Michalovce) and 0.10 μg/g
lipid (Svidnik/Stropkov) in our samples.
Hovander et al. (2006) reported lipid-adjusted
median 4-OH-CB187 concentrations of
0.13 μg/g (Michalovce) and 0.058 μg/g lipid
(Svidnik/Stropkov), whereas we measured 0.02
and 0.01 μg/g lipid, respectively. When the
two studies were compared for the concentra-
tions of specific congeners of PCBs and
OH-PCB metabolites, the study by Hovander
et al. (2006) showed higher concentrations.
However, the populations were not directly
comparable, because the report of Hovander
et al. was based on a sample of men and
women 20–59 years of age, whereas our sam-
ples included a narrower, younger age range
in women only. PCBs were strongly related to
age (Kocan et al. 2004; Sandau et al. 2000)
and additionally, blood lipid levels increase
during the last half of pregnancy (Herrera
et al. 2004).
In the present study we demonstrate that
the population in the eastern Slovakia area is
still exposed to high levels of environmental
PCBs two decades after the production of
PCBs stopped, including mothers who were
born after cessation. We also found that this
population carries significant concentrations
of OH-PCB metabolites. Although maternal
serum concentrations of OH-PCB metabolites
in Svidnik/Stropkov were lower than in
Michalovce, they were not trivial.
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